Femtech Industry Outlook, 2020-2024 – Innovation in Period Products, and Affordable & Personalized Fertility Solutions Present Lucrative Growth…

DUBLIN, Feb. 4, 2020 /PRNewswire/ -- The "Growth Opportunities in the Global Femtech Market, Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.

This study provides a glimpse of the background and the current trends in the Femtech industry that are driving the need for women-specific solutions, notes the market revenues as well as the potential of the market, and delves deeper into segments and sub-segments to highlight specific problem areas, solutions that cater to those issues, and their geographic distribution, application focus and target end-customers.

It also qualitatively notes the impact on the quality of life and the cost of care of these solutions, and their current penetration under each segment. Also covered are short profiles on some innovative companies in this space, other insights into Femtech that aren't necessarily covered in the rest of the study, and 11 growth opportunities that span the entire market.

Key Issues Addressed

Femtech is an emerging term and, as is the case with most new concepts, is poorly understood. While some relate Femtech only with products unique to the female anatomy (including consumer products), others dismiss it as just another term for a group of existing solutions.

The author believes it is a unique space and a place for new growth opportunities. One with the potential to cross $8 billion by 2020 and even $9 billion by 2024 (without considering the potential for cancer or pharmaceutical solutions) - if penetration and adoption of such solutions is rapid enough.

But what is Femtech? Femtech is defined as technology solutions such as device, diagnostic, product, software, app or services, or any combination thereof, that cater to the needs of women's health. Keeping women's health at the center, we follow a woman's life to see where Femtech solutions make an impact and therefore segment the market applications by the age of the woman.

In that sense, pre-menopause as our first segment covers the areas of menstrual care, fertility solutions (conception, contraception, egg freezing, and in-vitro fertility solutions) and pregnancy care; the Menopause segment covers symptom management solutions. Additionally, we also cover solutions under the General Health & Wellness segment, as well as Cancer and other Chronic Diseases segment.

Our analysis covers over 190 core and non-core Femtech companies and their solutions, representing a revenue of $601.2 million in 2019, which also means the penetration of these solutions is quite low. While low penetration is an expected outcome of a nascent market, we also attribute it to several other socio-cultural and infrastructural issues surrounding women, especially in lesser developed regions of the world, while noting the fact that today's demographic scenario points to a majority of the world's women living in the developing regions.

Investments across key Femtech segments through venture capital funding amounted to $1.69 billion in H1 2019. The solution formats include medical devices, wearables, apps on smartphones or plain services (and in some cases, a combination).

Key Topics Covered

Executive Summary

Market Overview

The Femtech Landscape

Drivers and Restraints-Total Femtech Market

Forecasts and Trends-Total Femtech Market

Market Potential-Total Femtech Market

Pre-Menopausal Care Segment Analysis

Menopausal Care Segment Analysis

Post-Menopausal/Geriatric Care Segment Analysis

General Health & Wellness Segment Analysis

Geographical Distribution

Other Insights Into the Femtech Industry

Growth Opportunities

For more information about this report visit https://www.researchandmarkets.com/r/ctlla1

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

Read more from the original source:
Femtech Industry Outlook, 2020-2024 - Innovation in Period Products, and Affordable & Personalized Fertility Solutions Present Lucrative Growth...

Related Post

Comments are closed.